Log in to save to my catalogue

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2748823390

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice

About this item

Full title

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice

Publisher

United States: Public Library of Science

Journal title

PloS one, 2022-12, Vol.17 (12), p.e0276717-e0276717

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Suppression of cardiac iinflammasome, which can be inhibited by Farnesoid X receptor (FXR) agonist, can ameliorate cardiac inflammation and fibrosis. Increased cardiac inflammasome decrease the abundance of regulatory T (Treg) cells and exacerbate cardiac dysfunction. Interaction between cardiomyocytes and Treg cells is involved in the development...

Alternative Titles

Full title

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2748823390

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2748823390

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0276717

How to access this item